PDYN-AS1: A Potential Drug Target and Biomarker (G727993)

Target Name: PDYN-AS1

NCBI ID: G727993

PDYN-AS1

Other Name(s): PDYN antisense RNA 1

PDYN-AS1: A Potential Drug Target and Biomarker

PDYN-AS1 (PDYN-antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. PDYN-AS1 is produced by the PDY gene and is known to regulate the cell cycle by inhibiting the activity of the cyclin D1 gene.

The PDY gene is a key regulator of the cell cycle in eukaryotic cells. It encodes a protein that is involved in the transition of cells from the G1 phase to the S phase of the cell cycle. The PDY protein functions as a negative regulator of the cyclin D1 gene, which encodes a protein that is involved in the recruitment of the nuclear chromatin at the G1 phase and the association with the microtubules of the

Protein Name: PDYN Antisense RNA 1

The "PDYN-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDYN-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets